Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 1
1986 2
1988 1
1989 3
1990 2
1999 5
2000 1
2002 13
2003 14
2004 19
2005 25
2006 23
2007 28
2008 46
2009 39
2010 41
2011 57
2012 53
2013 72
2014 90
2015 76
2016 97
2017 107
2018 137
2019 161
2020 157
2021 175
2022 245
2023 222
2024 244
2025 278
2026 240

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,399 results

Results by year

Filters applied: . Clear all
Page 1
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial.
Yi L, Maier AB, Tao R, Lin Z, Vaidya A, Pendse S, Thasma S, Andhalkar N, Avhad G, Kumbhar V. Yi L, et al. Geroscience. 2023 Feb;45(1):29-43. doi: 10.1007/s11357-022-00705-1. Epub 2022 Dec 8. Geroscience. 2023. PMID: 36482258 Free PMC article. Clinical Trial.
Mechanisms and treatment of atherosclerosis: focus on macrophages.
Zhang L, Li J, Kou Y, Shen L, Wang H, Wang Y, Ma R, Wu T, Yang X, Gu Y, Yi L. Zhang L, et al. Among authors: yi l. Front Immunol. 2024 Nov 6;15:1490387. doi: 10.3389/fimmu.2024.1490387. eCollection 2024. Front Immunol. 2024. PMID: 39569201 Free PMC article. Review.
Sequential targeting in multiple myeloma: talquetamab, a GPRC5D bispecific antibody, as a bridge to BCMA CAR-T therapy.
Dhakal B, Akhtar OS, Fandrei D, Jensen A, Banerjee R, Pan D, Richard S, Friend R, Rees M, Costello P, Vazquez Martinez M, Pasvolsky O, Wagner C, Davis JA, Castaneda Puglianini O, Reshef R, Afrough A, Dima D, Bhutani M, Nadeem O, Parrondo R, Freeman C, Mikkilineni L, Raza S, Anderson LD Jr, Kapoor P, Hosoya H, Chhabra S, Grajales-Cruz A, Gaballa M, Midha S, Alsina M, Sborov D, Patel K, Lin Y, Ferreri C, Gagelmann N, Kumar A, Hansen D, Cowan A, Costa LJ, Merz M, Sidana S. Dhakal B, et al. Among authors: lin y. Blood. 2025 Oct 23;146(17):2063-2072. doi: 10.1182/blood.2025029773. Blood. 2025. PMID: 40749169
Real-World Experience with Teclistamab for Relapsed/Refractory Multiple Myeloma from the US Myeloma Immunotherapy Consortium.
Razzo BM, Midha S, Portuguese AJ, Grajales-Cruz AF, De Menezes Silva Corraes A, Costello P, Liu Y, Sperling AS, Nadeem O, Dima D, Banerjee R, Cowan AJ, Afrough A, Anderson LD Jr, Lieberman-Cribbin A, Kaur G, Goyal A, Atrash S, Ferreri CJ, Voorhees PM, Pasvolsky O, Lee HC, Patel KK, Julian KL, Forsberg PA, Herr MM, Chhabra S, Parrondo RD, Lin Y, Chen A, Susanibar-Adaniya SP, Khouri J, Raza S, Anwer F, Vazquez-Martinez M, Castaneda Puglianini O, Sborov DW, Davis JA, Rossi A, Shune L, Bhurtel J, Hwang WT, Hansen DK, Sidana S, Garfall AL, Richard S. Razzo BM, et al. Among authors: lin y. Blood Cancer Discov. 2025 Nov 3;6(6):561-571. doi: 10.1158/2643-3230.BCD-24-0354. Blood Cancer Discov. 2025. PMID: 40629516
Checking in on proteostasis.
Sakata E, Hegde RS, Zhao YG, Ito T, Radford SE, Hatzgolou M, Jakob U, Park E, Lin Y, Deuerling E, Yang P, Choe YJ. Sakata E, et al. Among authors: lin y. Nat Struct Mol Biol. 2026 Mar;33(3):367-371. doi: 10.1038/s41594-026-01772-0. Nat Struct Mol Biol. 2026. PMID: 41826759 Free article. No abstract available.
2,399 results